Cargando…
WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea
Despite progress made in tuberculosis control worldwide, the disease burden and treatment outcome of multidrug-resistant tuberculosis (MDR-TB) patients have remained virtually unchanged. In 2016, the World Health Organization released new guidelines for the management of MDR-TB. The guidelines are i...
Autor principal: | Jeon, Doosoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617849/ https://www.ncbi.nlm.nih.gov/pubmed/28905529 http://dx.doi.org/10.4046/trd.2017.0049 |
Ejemplares similares
-
Latent tuberculosis infection: recent progress and challenges in South Korea
por: Jeon, Doosoo
Publicado: (2020) -
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
por: Falzon, Dennis, et al.
Publicado: (2017) -
Medical Management of Drug-Resistant Tuberculosis
por: Jeon, Doosoo
Publicado: (2015) -
Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design
por: Mok, Jeong Ha, et al.
Publicado: (2017) -
Additional Drug Resistance in Patients with Multidrug-resistant Tuberculosis in Korea: a Multicenter Study from 2010 to 2019
por: Lee, Taehoon, et al.
Publicado: (2021)